Dissemin is shutting down on January 1st, 2025

Published in

Wiley Open Access, Journal of the American Heart Association, 3(6), 2017

DOI: 10.1161/jaha.116.005254

Links

Tools

Export citation

Search in Google Scholar

Metabolic Mediators of the Effects of Family History and Genetic Risk Score on Coronary Heart Disease—Findings From the Malmö Diet and Cancer Study

Journal article published in 2017 by Josef Fritz ORCID, Dov Shiffman, Olle Melander, Hayato Tada, Hanno Ulmer
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Background Family history of coronary heart disease ( CHD ) as well as genetic predisposition to CHD assessed by a genetic risk score ( GRS ) are predictors of CHD risk. It is, however, uncertain to what extent these risk predictors are mediated by major metabolic pathways. Methods and Results Total effects of self‐reported family history and a 50‐variant GRS ( GRS 50), as well as effects mediated by apolipoprotein B and A‐I (apoB, apoA‐I), blood pressure, and diabetes mellitus, on incidence of CHD were estimated in 23 595 participants of the Malmö Diet and Cancer study (a prospective, population‐based study). During a median follow‐up of 14.4 years, 2213 participants experienced a first CHD event. Family history of CHD and GRS 50 (highest versus other quintiles) were associated with incident CHD , with hazard ratios of 1.52 (95% CI : 1.39–1.65) and 1.53 (95% CI : 1.39–1.68), respectively, after adjusting for age, sex, and smoking status. Small proportions of the family history effect were mediated by metabolic risk factors: 8.3% (95% CI : 5.8–11.7%) by the apoB pathway, 1.7% (95% CI : 0.2–3.4%) by apoA‐I, 8.5% (95% CI : 5.9–12.0%) by blood pressure, and 1.5% (95% CI : −0.8% to 3.8%) by diabetes mellitus. Similarly, small proportions of GRS 50 were mediated: 8.1% (95% CI : 5.5–11.8%) by apoB, 1.2% (95% CI : 0.5–3.0%) by apoA‐I, 4.2% (95% CI : 1.3–7.5%) by blood pressure, and −0.9% (95% CI : −3.7% to 1.6%) by diabetes mellitus. Conclusions A fraction of the CHD risk associated with family history or with GRS 50 is mediated through elevated blood lipids and hypertension, but not through diabetes mellitus. However, a major part (≥80%) of the genetic effect operates independently of established metabolic risk factor pathways.